FDA.reportPublic FDA data

Clonazepam

Product NDC
51655-865
11-digit product format
516550865
Labeler code
51655
Product ID
51655-865_75c6ea63-192e-eea5-e053-2991aa0aa879
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Clonazepam
Dosage form
TABLET
Route
ORAL
Labeler
Northwind Pharmaceuticals
Application
ANDA074569
Marketing category
ANDA
Marketing start
2014-06-01
Marketing end
0000-00-00
Substance
CLONAZEPAM
Active strength
1 mg/1
Pharmacologic classes
Benzodiazepine [EPC],Benzodiazepines [CS]
DEA schedule
CIV
NDC exclude flag
No
Listing certified through
2019-12-31
Current FDA listing
Historical FDA.report record

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
51655-865-522026-01-13C16284748780-19d75b9d0-8fe0-f424-e053-dadaa90a57ce1bb6e294-1b2f-48d4-8469-a3fa1c46a4ac
51655-865-522020-01-31C16284748780-19d75b9d0-8fe0-f424-e053-dadaa90a57ce1bb6e294-1b2f-48d4-8469-a3fa1c46a4ac

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
CLONAZEPAMACTIVE INGREDIENT5PE9FDE8GBCLONAZEPAM TABLET [NORTHWIND PHARMACEUTICALS]1
CLONAZEPAMACTIVE MOIETY5PE9FDE8GBCLONAZEPAM TABLET [NORTHWIND PHARMACEUTICALS]1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
51655-865CLONAZEPAM TABLET [NORTHWIND PHARMACEUTICALS]2Legacy NDC20180919_1bb6e294-1b2f-48d4-8469-a3fa1c46a4ac.zip